Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KASHIF ALI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1851423388
CMS profile
310504
Location
SILVER SPRING, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$133,301.27

246 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $64,050.63 56
GENZYME CORPORATION $40,119.56 31
AstraZeneca Pharmaceuticals LP $5,624.52 5
Janssen Biotech, Inc. $4,422.47 13
Global Blood Therapeutics, Inc. $4,116.26 7
Fresenius Kabi USA, LLC $2,550.00 1
Stemline Therapeutics Inc. $1,730.92 2
AbbVie Inc. $1,702.25 5
Heron Therapeutics, Inc. $1,400.00 1
Taiho Oncology, Inc. $1,394.12 2
Rigel Pharmaceuticals, Inc. $1,346.90 5
Novartis Pharmaceuticals Corporation $1,198.87 21
Adaptive Biotechnologies Corporation $1,000.00 1
BeiGene, Ltd. $525.00 1
Seagen Inc. $187.86 5
Boehringer Ingelheim Pharmaceuticals, Inc. $168.18 3
Merck Sharp & Dohme Corporation $150.39 10
PFIZER INC. $140.82 8
Amgen Inc. $134.74 6
Pharmacyclics LLC, An AbbVie Company $104.99 4
Secura Bio, Inc. $91.30 4
Incyte Corporation $91.18 4
Myriad Genetic Laboratories, Inc. $87.30 2
Janssen Pharmaceuticals, Inc $77.66 5
Exelixis Inc. $70.67 3
Celgene Corporation $67.09 4
Lilly USA, LLC $60.35 3
Regeneron Healthcare Solutions, Inc. $56.48 3
Dendreon Pharmaceuticals LLC $52.15 2
Takeda Pharmaceuticals U.S.A., Inc. $51.11 2
Pharmacosmos Therapeutics Inc. $47.14 2
Tactile Systems Technology Inc $44.75 3
PUMA BIOTECHNOLOGY, INC. $43.07 2
Eisai Inc. $40.32 2
Bayer HealthCare Pharmaceuticals Inc. $36.87 2
TG THERAPEUTICS, INC. $24.90 1
EMD Serono, Inc. $23.29 1
Clovis Oncology, Inc. $23.14 1
Dova Pharmaceuticals $22.80 1
Epizyme, Inc., $22.27 1
Genentech USA, Inc. $21.63 1
Kyowa Kirin, Inc. $21.28 1
Daiichi Sankyo Inc. $20.99 1
Blueprint Medicines Corporation $20.70 1
MorphoSys, US Inc. $20.32 1
Kite Pharma, Inc. $19.76 1
Acrotech Biopharma LLC $17.95 1
Alexion Pharmaceuticals, Inc. $16.51 1
ARRAY BIOPHARMA INC $14.73 1
TOLMAR Pharmaceuticals, Inc. $13.16 1
Gilead Sciences, Inc. $11.92 1

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

246 matching records · $133,301.27 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 246 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 246.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $23.5312/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812583505 CMS
Eisai Inc. $18.2312/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818072701 CMS
Global Blood Therapeutics, Inc. $5.8812/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835337747 CMS
GENZYME CORPORATION $1,918.0012/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843594893 CMS
Novartis Pharmaceuticals Corporation $83.3312/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812583525 CMS
E.R. Squibb & Sons, L.L.C. $426.4812/15/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404357 CMS
E.R. Squibb & Sons, L.L.C. $51.6312/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404359 CMS
E.R. Squibb & Sons, L.L.C. $657.5512/15/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404361 CMS
Merck Sharp & Dohme Corporation $19.3112/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848364001 CMS
Amgen Inc. $18.5812/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026825496935 CMS
AstraZeneca Pharmaceuticals LP $36.8812/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829966863 CMS
GENZYME CORPORATION $108.3512/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843594895 CMS
GENZYME CORPORATION $2,877.0012/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843594897 CMS
Janssen Biotech, Inc. $99.9912/09/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788750829 CMS
Janssen Biotech, Inc. $5.1612/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788750841 CMS
E.R. Squibb & Sons, L.L.C. $5.6112/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026858712891 CMS
Merck Sharp & Dohme Corporation $14.4212/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848650189 CMS
E.R. Squibb & Sons, L.L.C. $2,635.0012/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404347 CMS
Stemline Therapeutics Inc. $80.9212/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026834862871 CMS
Merck Sharp & Dohme Corporation $10.8712/02/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848309233 CMS
Novartis Pharmaceuticals Corporation $20.6112/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812583503 CMS
Regeneron Healthcare Solutions, Inc. $20.3411/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026809554693 CMS
Novartis Pharmaceuticals Corporation $13.6011/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812583501 CMS
E.R. Squibb & Sons, L.L.C. $600.0011/26/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404379 CMS
AstraZeneca Pharmaceuticals LP $3,330.0011/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830076441 CMS
Global Blood Therapeutics, Inc. $3.0811/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835337745 CMS
E.R. Squibb & Sons, L.L.C. $412.5011/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404345 CMS
TOLMAR Pharmaceuticals, Inc. $13.1611/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026836507125 CMS
Janssen Pharmaceuticals, Inc $17.4911/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788750853 CMS
Novartis Pharmaceuticals Corporation $83.3311/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026812583523 CMS
Acrotech Biopharma LLC $17.9511/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026855378087 CMS
Seagen Inc. $21.9411/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832149461 CMS
Taiho Oncology, Inc. $1,375.0011/11/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843377077 CMS
E.R. Squibb & Sons, L.L.C. $1,400.0011/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404339 CMS
Lilly USA, LLC $15.1211/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026818590349 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.9111/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026819848463 CMS
Epizyme, Inc., $22.2711/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832337721 CMS
Rigel Pharmaceuticals, Inc. $19.7011/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026854328259 CMS
Amgen Inc. $25.5911/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026826372433 CMS
Seagen Inc. $30.7910/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832149445 CMS
GENZYME CORPORATION $959.0010/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843594883 CMS
Pharmacyclics LLC, An AbbVie Company $23.7910/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026781007653 CMS
E.R. Squibb & Sons, L.L.C. $5,300.0010/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404349 CMS
Dova Pharmaceuticals $22.8010/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026849749607 CMS
GENZYME CORPORATION $18.3110/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843594855 CMS
Janssen Pharmaceuticals, Inc $8.0810/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788750847 CMS
Janssen Pharmaceuticals, Inc $18.2510/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788750849 CMS
E.R. Squibb & Sons, L.L.C. $24.8610/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404331 CMS
E.R. Squibb & Sons, L.L.C. $4.9710/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026783404333 CMS
Incyte Corporation $14.9910/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026835555257 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $96,857.80 242
PY2020 $24,496.91 200
PY2021 $133,301.27 246
PY2022 $197,546.09 282
PY2023 $168,322.64 274
PY2024 $221,790.02 302
PY2025 $144,918.86 277

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
KASHIF ALI, NPI 1851423388. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1851423388.
APA 7
IndustryPayments. (2026). KASHIF ALI, NPI 1851423388 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1851423388
Bluebook
KASHIF ALI, NPI 1851423388, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1851423388.

Source: Centers for Medicare & Medicaid Services, Open Payments.